Literature DB >> 20673720

Fourth ventricular chordoid meningioma.

Joshua J Wind1, Robert V Jones, Fabio Roberti.   

Abstract

The chordoid variant of meningioma is a histological subtype which carries with it a more aggressive clinical course and a propensity for recurrence. Similar to other meningioma subtypes, this lesion is encountered typically in the supratentorial compartment, often along the cerebral convexities. The chordoid meningioma subtype is found primarily in the adult population, and may occasionally be associated with the systemic manifestations of Castleman's disease. We present an adult patient with a rare chordoid meningioma located within the fourth ventricle. This lesion was treated with gross total resection. Chordoid meningioma must be considered within the differential diagnosis of intraventricular tumors. This histological subtype of meningioma warrants close follow-up. The patient must also be evaluated for systemic manifestations of Castleman's disease. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673720     DOI: 10.1016/j.jocn.2010.03.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

Review 1.  Predictors of recurrence in the management of chordoid meningioma.

Authors:  Winward Choy; Leonel Ampie; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  J Neurooncol       Date:  2015-09-26       Impact factor: 4.130

2.  Intraparenchymal papillary meningioma of brainstem: case report and literature review.

Authors:  Xiao-Bing Jiang; Chao Ke; Zhi-An Han; Shao-Hua Lin; Yong-Gao Mou; Rong-Zhen Luo; Shao-Xiong Wu; Zhong-Ping Chen
Journal:  World J Surg Oncol       Date:  2012-01-12       Impact factor: 2.754

3.  Chordoid meningioma: a retrospective series of seven consecutive cases.

Authors:  Emiliano Passacantilli; Gennaro Lapadula; Federico Caporlingua; Jacopo Lenzi; Manila Antonelli; Francesca Santoro; Antonio Santoro
Journal:  Neurol Sci       Date:  2013-04-18       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.